Efficacy of treatments for Demodex blepharitis: A systematic review and meta-analysis.


Journal

The ocular surface
ISSN: 1937-5913
Titre abrégé: Ocul Surf
Pays: United States
ID NLM: 101156063

Informations de publication

Date de publication:
10 2019
Historique:
received: 22 02 2019
revised: 21 05 2019
accepted: 17 06 2019
pubmed: 24 6 2019
medline: 15 12 2020
entrez: 24 6 2019
Statut: ppublish

Résumé

We conducted a systematic review and meta-analysis to evaluate the efficacy of different treatment for Demodex blepharitis. Parameters studied were mites count, improvement of symptoms and mites' eradication, stratified on type of treatments and mode of delivery of treatments (local or systemic). The PubMed, Cochrane Library, Embase, ClinicalTrials.gov, Google scholar and Science Direct databases were searched for studies reporting an efficacy of treatments for Demodex blepharitis. We included 19 studies (14 observational and 5 randomized clinical trials), for a total of 934 patients, 1741 eyes, and 13 different treatments. For mites count, eradication rate, and symptoms improvement, meta-analysis included fifteen, fourteen and thirteen studies, respectively. The overall effect sizes for efficiency of all treatments, globally, were 1.68 (95CI 1.25 to 2.12), 0.45 (0.26-0.64), and 0.76 (0.59-0.90), respectively. Except usual lid hygiene for mites count, Children's Hospital of Eastern Ontario ointment (CHEO) for both eradication rate and symptoms, and CHEO, 2% metronidazole ointment, and systemic metronidazole for eradication rate, all treatments were efficient. Stratified meta-analysis did not show significant differences between local and systemic treatments (1.22, 0.83 to 1.60 vs 2.24, 1.30 to 3.18 for mites count; 0.37, 0.21 to 0.54 vs 0.56, 0.06 to 0.99 for eradication rate; and 0.77, 0.58 to 0.92 vs 0.67, 0.25 to 0.98 for symptoms improvement). We reported the efficiency of the different treatments of Demodex blepharitis. Because of less systemic side effects, local treatments seem promising molecules in the treatment of Demodex blepharitis.

Identifiants

pubmed: 31229586
pii: S1542-0124(19)30065-5
doi: 10.1016/j.jtos.2019.06.004
pii:
doi:

Substances chimiques

Anti-Infective Agents, Local 0
Antiparasitic Agents 0
Miotics 0
Pilocarpine 01MI4Q9DI3
Metronidazole 140QMO216E
Tea Tree Oil 68647-73-4
Ivermectin 70288-86-7

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

655-669

Informations de copyright

Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Auteurs

Valentin Navel (V)

University Hospital of Clermont-Ferrand, CHU Clermont-Ferrand, Ophthalmology, F-63000, Clermont-Ferrand, France. Electronic address: vnavel@chu-clermontferrand.fr.

Aurélien Mulliez (A)

University Hospital of Clermont-Ferrand, CHU Clermont-Ferrand, Biostatistics Unit, Clinical Research and Innovation Direction, F-63000, Clermont-Ferrand, France.

Cédric Benoist d'Azy (C)

University Hospital of Clermont-Ferrand, CHU Clermont-Ferrand, Ophthalmology, F-63000, Clermont-Ferrand, France.

Julien S Baker (JS)

University of the West of Scotland, Institute for Clinical Exercise and Health Science, Hamilton, United Kingdom.

Jean Malecaze (J)

University Hospital of Clermont-Ferrand, CHU Clermont-Ferrand, Ophthalmology, F-63000, Clermont-Ferrand, France.

Frédéric Chiambaretta (F)

University Hospital of Clermont-Ferrand, CHU Clermont-Ferrand, Ophthalmology, F-63000, Clermont-Ferrand, France.

Frédéric Dutheil (F)

University Hospital of Clermont-Ferrand, CNRS, LaPSCo, Physiological and Psychosocial Stress, CHU Clermont-Ferrand, Preventive and Occupational Medicine, Witty Fit, F-63000, Clermont-Ferrand, France; Australian Catholic University, Faculty of Health, School of Exercise Science, Melbourne, Victoria, 3065, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH